Commentary to Targeted therapy for advanced cutaneous melanoma.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 208, doi. 10.5603/OCP.2022.0010
- By:
- Publication type:
- Article
Works matching IS 24501654 AND DT 2022 AND VI 18 AND IP 3
Results: 8
1
2
Targeted therapy for advanced cutaneous melanoma.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 197, doi. 10.5603/OCP.2022.0005
- By:
- Publication type:
- Article
3
Commentary to Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer -- updated MONALEESA-3 results.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 195, doi. 10.5603/OCP.2021.0035
- By:
- Publication type:
- Article
4
Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer -- updated MONALEESA-3 results.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 189, doi. 10.5603/OCP.2021.0034
- By:
- Publication type:
- Article
5
Evolution of prostate cancer therapy. Part 1.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 177, doi. 10.5603/OCP.2021.0001
- By:
- Publication type:
- Article
6
Cisplatin -- properties and clinical application.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 166, doi. 10.5603/OCP.2022.0020
- By:
- Publication type:
- Article
7
The rehabilitation of cancer patients and the role of nurses: a scoping review.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 147, doi. 10.5603/OCP.2022.0018
- By:
- Publication type:
- Article
8
Different MET gene alterations in lung adenocarcinoma patients.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 139, doi. 10.5603/OCP.2022.0019
- By:
- Publication type:
- Article